News Headlines
15th October 2012
Biopharm Services wins two awards at the 2012 BioProcess International Awards
The Manufacturing Processing Pillar Thought leader of the decade finalist
Andrew Sinclair: Developing Product life cycle Management Tools
Andrew Sinclair continues to anticipate issues and challenges faced by the biopharmaceutical industry and ways to address them. He
has been instrumental in helping the industry deliver affordable biologics by focusing on ways to improve cost effectiveness of manufactured
drugs. Over the past 10 years, he worked to communicate the impact of process and technology choices on product cost and manufacturability,
developing widely used software tools to enable companies to understand the implications of their process and technology choices.
He is now actively promoting the next game-changing topic: process knowledge management for driving efficiency and reducing development and
manufacturing costs.
The Upstream Processing Pillar Collaboration of the decade finalist
Project: Xcellerex AMP Program. Team: (DARPA – AMP) xcellerex inc., Pfenex, inc., deltaDoT, Ltd., Biopharm services, Ltd., and the
Latham BioPharm Group
In 2007, the US Defense Advanced Research Projects Agency (DARPA) launched an ambitious program, Accelerated Manufacture of Pharmaceuticals (AMP),
aimed at developing ultrafast biomanufacturing technologies. The Xcellerex AMP collaboration resulted in a high-efficiency bacterial expression
system to produce a model vaccine and antibody. The Pfēnex expression technology is based on Pseudomonas Fluorescens, which expresses recombinant
proteins at high titers. The system has developed a strong track record in producing a number of different types of complex molecules including
vaccines, virus-like particles, engineered proteins such as scaffolds, and antibody derivatives in addition to fully assembled MAbs.
16th August 2012
Andrew Sinclair, is through to the finals for Thought Leader of the Decade, manufacturing category, for the BioProcess
International Awards.
Click here for more information
1st February 2012
Biopharm Services has been awarded a UK technology strategy board grant to develop our software bioprocess database
application to support rapid bioprocess development and technology transfer to manufacturing. Extending the functionality
of the BioSolve platform to recipe management and facility fit.
ARCHIVE
3rd November 2011
Biopharm Service's Annual Bioprocess Simulation prize was awarded in to a team of undergraduate students at UCL's Department
of Biochemical Engineering for their work on "Application of BioSolve computer simulation tool for investigating the process
economics of antibody production. MORE